Vinayak K Prasad

45PUBLICATIONS
44CO-AUTHORS
Molecular targetsCommunications and media policyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Econometric and statistical methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Aug 14, 2025
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials.

Varun Jhanji, Jacob Duncan, Taylor Gardner

|Jul 10, 2025
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical Trials.

Varun Jhanji, Jacob Duncan, Taylor Gardner

|May 20, 2025
Characterization of bridging therapies in clinical trials leading to FDA approval of CAR-T cell therapies.

Victoria Kaestner, Alyson Haslam, Vinay Prasad

|Mar 25, 2025
The cost of emulated target trials: Is real-world data cheaper than randomized studies?

Mariana Barosa, Vinay Prasad

Pageof 8